Zetia Buyers Defend Class Cert. As 'Common Business Sense'
By Bryan Koenig · February 9, 2022, 5:33 PM EST
Direct buyers of cholesterol drug Zetia urged a Virginia federal court Tuesday to reject a recommendation against class certification in multidistrict litigation accusing Merck and Glenmark of scheming to delay generic...
To view the full article, register now.